FDA plans to establish a pilot program, with the input of the pharmaceutical industry, to help it develop an electronic, interoperable system that will track and trace prescription drugs through the supply chain, the agency said in a July 20 Federal Register notice.
But first FDA wants to get an estimate from industry on the time involved in
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?